Clinical Trials Browser

Burkitt Lymphoma, Colonic Neoplasms, Immunoblastic Lymphadenopathy, Leukemia, Hairy Cell, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Melanoma, Mycosis Fungoides, Rectal Neoplasms, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Leukemia, Large Granular Lymphocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell, Intraocular Lymphoma

NCT02431572 2020-04-28

A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy

Phase NA Completed

11 enrolled 8 charts

CNSDermatologic

Brain Neoplasms, Glioblastoma, Melanoma

NCT01449279 2020-03-02

Pilot Ipilimumab in Stage IV Melanoma Receiving Palliative Radiation Therapy

Phase 2 Completed

22 enrolled 14 charts

Dermatologic

Melanoma

NCT01996202 2019-07-05

A Pilot Study of Ipilumimab and Radiation in Poor Prognosis Melanoma

Phase 1 Completed

24 enrolled

Dermatologic

Melanoma

NCT02372708 2015-02-26

Clinical Research on the Treatments on Advanced Malignant Melanoma by Combining in Situ Immunotherapy and Laser Therapy

Completed

72 enrolled

Dermatologic

Melanoma

NCT00287196 2013-06-25

Immediate Radiotherapy or Observation After Surgery for Melanoma Involving Lymph Nodes

Phase 3 Completed

250 enrolled

Dermatologic

Lymphedema, Melanoma

Clinical Trials

MelPORT

In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors

Radiation Therapy, Plasma Exchange, and Immunotherapy (Pembrolizumab or Nivolumab) for the Treatment of Melanoma

Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Melanoma, and Lung Cancer

Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer

LauT1

RTN2

Ipilimumab and Local Radiation for Selected Solid Tumors

A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy

Pilot Ipilimumab in Stage IV Melanoma Receiving Palliative Radiation Therapy

A Pilot Study of Ipilumimab and Radiation in Poor Prognosis Melanoma

Clinical Research on the Treatments on Advanced Malignant Melanoma by Combining in Situ Immunotherapy and Laser Therapy

Immediate Radiotherapy or Observation After Surgery for Melanoma Involving Lymph Nodes